Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity-Reference-Cited by-同舟云学术

Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity

Published:2019-09-11 Issue:9 Volume:14 Page:e0218229
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yotsumoto Takafumi^ORCID,Morozumi Naomi,Nakamura Ryuichi,Jindo Toshimasa,Furuya Mayumi,Abe Yasuyuki,Nishimura Tomonari,Maeda Hiroaki,Ogasawara Hiroyuki,Minamitake Yoshiharu,Kangawa Kenji

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference18 articles.

1. Achondroplasia: Development, pathogenesis, and therapy;DM Ornitz;Dev Dyn,2017

2. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis;P Krejci;J Cell Sci,2005

3. Dwarfism and early death in mice lacking C-type natriuretic peptide;H Chusho;Proc Natl Acad Sci,2001

4. Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth with normal life-span;T Fujii;PLos One,2018

5. Foramen magnum stenosis and midface hypoplasia in C-Type natriuretic peptide deficient rats and its restoration by exogenous administration of CNP-53;T Yotsumoto;PLoS One,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. I nuovi farmaci per la terapia dell’acondroplasia;L'Endocrinologo;2022-11-15

2. Natriuretic Peptide-Based Novel Therapeutics: Long Journeys of Drug Developments Optimized for Disease States;Biology;2022-06-03

3. Expanding horizons of achondroplasia treatment: current options and future developments;Osteoarthritis and Cartilage;2021-12

4. New developments in the management of achondroplasia;Wiener Medizinische Wochenschrift;2020-03-06